相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements
Anna-Maria Hoffmann-Vold et al.
LANCET RHEUMATOLOGY (2020)
Is incident rheumatoid arthritis interstitial lung disease associated with methotrexate treatment? Results from a multivariate analysis in the ERAS and ERAN inception cohorts
Patrick Kiely et al.
BMJ OPEN (2019)
Short-term progression of interstitial lung disease in systemic sclerosis predicts long-term survival in two independent clinical trial cohorts
Elizabeth R. Volkmann et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis
Vanessa Hax et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial
Donald P. Tashkin et al.
LANCET RESPIRATORY MEDICINE (2016)
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
Peter C. Austin et al.
STATISTICS IN MEDICINE (2015)
Prediction of Pulmonary Complications and Long-Term Survival in Systemic Sclerosis
Svetlana I. Nihtyanova et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Clinical decision rule to predict the presence of interstitial lung disease in systemic sclerosis
Russell Steele et al.
ARTHRITIS CARE & RESEARCH (2012)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
分享论文
